“A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes” We describe here for the first time a…

TropIQ receives a Grand Challenges and Explorations award from the Bill & Melinda Gates Foundation to develop barcoded insect screens for optimization of artificial diets.

TropIQ staff co-authors the study ‘A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds’ that was published by Scientific…

TropIQ employees co-author the study ‘A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria’ that was published by Science Translational Medicine today.

TropIQ contributed to the study ‘Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate—Tackling the Cocktail Challenge’ that was published by Plos One today.

Nature publishes the paper ‘A novel multiple-stage antimalarial agent that inhibits protein synthesis’ that is co-authored by TropIQ.

TropIQ employees co-author the manuscript ‘Salinomycin and other ionophores as new class of antimalarial drugs with transmission blocking activity’ that appeared in Antimicrobial Agents and Chemotherapy today.

TropIQ employees co-author the manuscript Novel pantothenate derivatives for anti-malarial chemotherapy that appeared in Malaria Journal today.

Watch the full video here

In the publication “A combination of new screening assays for prioritization of transmission-blocking antimalarials

TropIQ and the California Research Institute for Biomedical Research (Calibr) enter a research collaboration. TropIQ will perform barcoded mosquito assay to support Calibr’s insecticide program.